# CPDA-1

NDC: 0942-6320
Generic name: Anticoagulant Citrate Phosphate Dextrose Adenine
Labeler / Manufacturer: Fenwal, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: SOLUTION
Routes: INTRAVENOUS
Marketing started: 20070604

FDA application: BN770420

## Active ingredients

- ADENINE: 19.3 mg/70mL
- ANHYDROUS CITRIC ACID: 209 mg/70mL
- DEXTROSE MONOHYDRATE: 2.23 g/70mL
- SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE: 155 mg/70mL
- TRISODIUM CITRATE DIHYDRATE: 1.84 g/70mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0942-6320"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0942-6320
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2557199a-5f60-49d8-b093-1e0700211243